Found: 6
Select item for more details and to access through your institution.
High-Dose Ambroxol Therapy in Type 1 Gaucher Disease Focusing on Patients with Poor Response to Enzyme Replacement Therapy or Substrate Reduction Therapy.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6732, doi. 10.3390/ijms24076732
- By:
- Publication type:
- Article
Brain-Derived Neurotrophic Factor (BDNF) Is Associated with Platelet Activity and Bleeding Tendency in Patients with Gaucher Disease.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 13982, doi. 10.3390/ijms232213982
- By:
- Publication type:
- Article
Rapid home therapy infusion of velaglucerase alfa in naïve patients with Gaucher disease.
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 3, p. 398, doi. 10.1111/imj.16179
- By:
- Publication type:
- Article
Rapid velaglucerase alfa infusion for Gaucher disease: 5‐year data.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 9, p. 1645, doi. 10.1111/imj.15898
- By:
- Publication type:
- Article
Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Risk of postpartum hemorrhage in multiparous women with Gaucher disease: A call for reconsidering enzyme replacement therapy in all pregnant patients.
- Published in:
- Journal of Inherited Metabolic Disease, 2021, v. 44, n. 5, p. 1165, doi. 10.1002/jimd.12382
- By:
- Publication type:
- Article